A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia (Q34455145)

2 August 2017

A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia (English)

1 reference

2 August 2017

1 reference

1 reference

16

Charles-Edouard Luyt

0 references

Didier Pittet

2

object named as

Didier Pittet

1 reference

2 August 2017

1

Marin Kollef

1 reference

2 August 2017

11

Alain Mercat

1 reference

2 August 2017

6

Marc Bonten

1 reference

2 August 2017

9

Henry Fuchs

1 reference

2 August 2017

4

Jean Chastre

1 reference

2 August 2017

Miguel Sánchez García

3

1 reference

2 August 2017

Jean-Yves Fagon

5

1 reference

2 August 2017

Robert Hyzy

7

1 reference

2 August 2017

Thomas R Fleming

8

1 reference

2 August 2017

Lisa Bellm

10

1 reference

2 August 2017

Rafael Mañez

12

1 reference

2 August 2017

Antonio Martínez

13

1 reference

2 August 2017

Philippe Eggimann

14

1 reference

2 August 2017

Martín Daguerre

15

1 reference

2 August 2017

Prevention of Pneumonia Study (POPS-1) Trial Group

17

1 reference

2 August 2017

language of work or name

English

0 references

publication date

28 September 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

1 reference

2 August 2017

173

1 reference

2 August 2017

1

1 reference

2 August 2017

91-97

1 reference

Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia--Chicago, Illinois, May 2002.

2 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Effect of ventilator-associated pneumonia on mortality and morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Impact of ventilator-associated pneumonia on resource utilization and patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

The standardization of bronchoscopic techniques for ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Testing for treatment differences with dropouts present in clinical trials--a composite approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Selective decontamination of the digestive tract in multiple trauma patients. A prospective double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

Iseganan HCl: a novel antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

A Controlled Trial in Intensive Care Units of Selective Decontamination of the Digestive Tract with Nonabsorbable Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200504-656OC

10.1164/RCCM.200504-656OC

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference